Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kamel Khalili
Florida International University, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Excision BioTherapetuics, LLC
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Temple University has advised that Dr. Khalili is a founding member, scientific advisory board member and IP holder of a privately held company called Excision BioTherapeutics. The company is currently working on commercializing their technology and there is no dollar amount awarded to it yet. Dr. Khalili has indicated that the research being conducted on this project relates to the technology.
Nanotechnology Based Gene Editing to Eradicate HIV Brain Reservoir in Drug Abusers
NARRATIVE Morphine has been shown to complicate the severity of HIV-1 and its progression in the brain. The current antiviral therapy has failed to eradicate the HIV-1 genome and alleviate the complications caused by morphine and HIV-1 in the CNS. Our new strategy, which efficiently eliminates the HIV-1 genome from the infected cells along with the use of a robust delivery system such as nanoparticles, offers a new avenue for developing a method for eradication of HIV-1 and a cure for neuroAIDS.
Filed on March 31, 2017.
Tell us what you know about Kamel Khalili's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Kamel Khalili filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kamel Khalili | Drexel University | Conflict of Interest | Excision BioTherapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.